S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968016.33010.55 |
| _version_ | 1827331170398896128 |
|---|---|
| author | Stacey Dillon Rupert Davies Jason Lickliter Kristi Mclendon Kristi Kristi L. Manjarrez, Bs Alina Smith Krystalyn Hudson Lori Blanchfield Russel Sanderson Allison Chunyk Tiffany Blair Amanda Enstrom Hany Zayed Stanford Peng |
| author_facet | Stacey Dillon Rupert Davies Jason Lickliter Kristi Mclendon Kristi Kristi L. Manjarrez, Bs Alina Smith Krystalyn Hudson Lori Blanchfield Russel Sanderson Allison Chunyk Tiffany Blair Amanda Enstrom Hany Zayed Stanford Peng |
| author_sort | Stacey Dillon |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:32:14Z |
| format | Article |
| id | doaj.art-1a832cac7f9947ab852ebd7f79e00d1d |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:32:14Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-1a832cac7f9947ab852ebd7f79e00d1d2024-03-03T10:10:28ZengWileyHemaSphere2572-92412023-08-017e330105510.1097/01.HS9.0000968016.33010.55202308003-00178S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASESStacey Dillon0Rupert Davies1Jason Lickliter2Kristi Mclendon3Kristi Kristi L. Manjarrez, Bs4Alina Smith5Krystalyn Hudson6Lori Blanchfield7Russel Sanderson8Allison Chunyk9Tiffany Blair10Amanda Enstrom11Hany Zayed12Stanford Peng131 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States2 Nucleus Network Melbourne Clinic, Melbourne, Australia3 Nucleus Network Brisbane Clinic, Herston, Australia1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States4 Columbia University, New York, United States1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United States1 Alpine Immune Sciences, Inc., Seattle, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000968016.33010.55 |
| spellingShingle | Stacey Dillon Rupert Davies Jason Lickliter Kristi Mclendon Kristi Kristi L. Manjarrez, Bs Alina Smith Krystalyn Hudson Lori Blanchfield Russel Sanderson Allison Chunyk Tiffany Blair Amanda Enstrom Hany Zayed Stanford Peng S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES HemaSphere |
| title | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_full | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_fullStr | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_full_unstemmed | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_short | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_sort | s276 povetacicept alpn 303 a potent dual baff april antagonist for the treatment of autoimmune cytopenias and other antibody related diseases |
| url | http://journals.lww.com/10.1097/01.HS9.0000968016.33010.55 |
| work_keys_str_mv | AT staceydillon s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT rupertdavies s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT jasonlickliter s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT kristimclendon s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT kristikristilmanjarrezbs s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT alinasmith s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT krystalynhudson s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT loriblanchfield s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT russelsanderson s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT allisonchunyk s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT tiffanyblair s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT amandaenstrom s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT hanyzayed s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT stanfordpeng s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases |